Carbon Footprint Assessment for Robotic, Laparoscopic and Open Colorectal Operations to Enhance Environmental Sustainability
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Feb 19, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the environmental impact of different types of colorectal surgeries, which involve removing part of the intestine. Researchers want to compare robotic, laparoscopic (minimally invasive), and open surgeries to see how much carbon dioxide (CO2) each method produces. By understanding the carbon footprint of these procedures, they hope to find ways to make them more environmentally friendly. To do this, they will measure the materials and tools used during surgery, the energy consumed, and the CO2 emissions from anesthesia.
If you're considering participating in this trial, you need to be an adult aged 18 or older who is scheduled for an elective colorectal surgery that involves removing part of the bowel. The study is looking for patients who are generally healthy or have manageable health issues. However, if your surgery is an emergency or if there are complications, you wouldn’t be eligible. Participants will help researchers gather important data that could lead to more sustainable surgical practices in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Elective operations which are routinely performed robot-assisted, laparoscopic and open:
- • Only Colorectal procedures involving a bowel resection will be included (colectomies (right/left), anterior resections)
- • General anesthesia
- • Aged \> 18 years
- • ASA classification from I to III
- Exclusion Criteria:
- • Procedures, which were uncompleted due to complications
- • Procedures, which switched modality (laparoscopic to open, robot-assisted to open)
- • Emergency procedures (mainly laparoscopic, unforeseen risk factors that lead to a change of modality, higher volume of used compressions and other materials).
- • Aged younger than 18
- • ASA classification \> III
- • Vulnerable patient groups (pregnancy, patients with mental disability)
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Basel, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported